Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
Do you avoid Daptomycin use when there is evidence of septic pulmonary emboli?
Related Questions
What is your approach to managing antimicrobial therapy for intra-abdominal infections to avoid unnecessary double anaerobic coverage, in light of associated risks and guidelines?
Do you switch to an alternative agent for C difficile colitis for a patient with suspected infection and positive testing who continues to have >3 watery bowel movements daily despite multiple days of oral vancomycin treatment?
Do you recommend treatment of male partners for patients with recurrent bacterial vaginosis?
What role could emerging technologies, such as antimicrobial coatings or biofilm-disrupting agents, play in reducing the incidence of CIED infections?
In what situations would you treat a corynebacterium positive blood culture as a true pathogen compared to a contaminant?
How would you manage an early postoperative spinal implant infection when intraoperative cultures while on antibiotics are negative, no frank purulence or other evidence of infection is observed during washout, but there were fascial defects and fluid tracking down to the hardware?
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
How do you approach patients who continue to experience pruritus and ongoing concern for persistent scabies despite having completed appropriate treatment?
Are there specific organisms other than s. aureus in which you offer indefinite antibiotic suppression in medically treated prosthetic valve endocarditis?
Would you use daptomycin to consolidate therapy in a patient with polymicrobial VRE and rothia bacteremia?
